Literature DB >> 12194813

Neuroendovascular Rescue: Interventional Treatment of Acute Ischemic Stroke.

Camilo R. Gomez1, Sean C. Orr, Rodney D. Soto.   

Abstract

Stroke continues to be a major health problem for our society. Despite the proven effectiveness of intravenous tissue plasminogen activator (t-PA) for the treatment of acute ischemic stroke, only a minority of patients qualify for this type of therapy. Furthermore, the existing literature has demonstrated that t-PA is not as effective in the treatment of occlusion of large cerebral arteries. The benefit-to-risk assessment of this subpopulation of stroke patients makes them the best candidates for neuroendovascular rescue. This term refers to the intra-arterial application of techniques designed to promote arterial recanalization, and includes intra-arterial thrombolysis and antithrombotic agents, direct mechanical disruption, angioplasty, stenting, embolectomy, and vasoactive pharmacologic intervention. The timing and choice of these procedures, as well as the care of the patient prior to, during, and after the intervention, requires a highly focused and expert approach.

Entities:  

Year:  2002        PMID: 12194813     DOI: 10.1007/s11936-002-0020-6

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  35 in total

1.  Angioplasty of the occluded internal carotid artery.

Authors:  M P Spearman; C A Jungreis; L R Wechsler
Journal:  AJNR Am J Neuroradiol       Date:  1995-10       Impact factor: 3.825

2.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.

Authors:  G J del Zoppo; K Poeck; M S Pessin; S M Wolpert; A J Furlan; A Ferbert; M J Alberts; J A Zivin; L Wechsler; O Busse
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

4.  Occlusion of the basilar artery; a clinical and pathological study.

Authors:  C S KUBIK; R D ADAMS
Journal:  Brain       Date:  1946-06       Impact factor: 13.501

5.  Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease.

Authors:  H Zeumer; W Hacke; E B Ringelstein
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

6.  Basilar artery occlusion: clinical and radiological correlation.

Authors:  C R Archer; S Horenstein
Journal:  Stroke       Date:  1977 May-Jun       Impact factor: 7.914

7.  Early hemicraniectomy in patients with complete middle cerebral artery infarction.

Authors:  S Schwab; T Steiner; A Aschoff; S Schwarz; H H Steiner; O Jansen; W Hacke
Journal:  Stroke       Date:  1998-09       Impact factor: 7.914

8.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

9.  Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging.

Authors:  S Warach; J Gaa; B Siewert; P Wielopolski; R R Edelman
Journal:  Ann Neurol       Date:  1995-02       Impact factor: 10.422

10.  Fast magnetic resonance diffusion-weighted imaging of acute human stroke.

Authors:  S Warach; D Chien; W Li; M Ronthal; R R Edelman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

View more
  2 in total

1.  Endovascular management of intracerebral and subarachnoid hemorrhage.

Authors:  Franklin A Marden; Soma Sinha Roy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

2.  The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism.

Authors:  A Bose; H Henkes; K Alfke; W Reith; T E Mayer; A Berlis; V Branca; S Po Sit
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.